Pathological complete response after neoadjuvant chemotherapy is an independent predictive factor irrespective of simplified breast cancer intrinsic subtypes: a landmark and two-step approach analyses from the EORTC 10994/BIG 1-00 phase III trial

H. Bonnefoi, S. Litiere, M. Piccart, G. Macgrogan, P. Fumoleau, E. Brain, T. Petit, P. Rouanet, J. Jassem, C. Moldovan, A. Bodmer, K. Zaman, T. Cufer, M. Campone, E. Luporsi, P. Malmstrom, G. Werutsky, J. Bogaerts, J. Bergh, D. A. Cameron

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)1128-1136
JournalAnnals of Oncology
Issue number6
Publication statusPublished - 1 Jun 2014

Cite this